Tagged Articles

asthma-related death 2 articles

Europe’s drug authority considers heart risks with testosterone replacement therapy

European drug regulators are weighing whether the benefits of testosterone replacement therapy are worth the risk of life threatening cardiovascular events. Testosterone therapy, such as AbbVie’s AndroGel, is approved in both the United States and Europe for the treatment of hypogondaism, a condition in which the body does not produce enough testosterone. This can cause symptoms such as low sex drive and muscle loss. In recent years, makers of testosterone treatments have heavily marketed the drugs directly to consumers, asking men if they suffer from what they deem symptoms of “Low-T” – weight gain, fatigue, and general grumpiness. The campaign was ... Read More

Lung treatment safety labels now carry asthma-related death warning

The safety labels on Long-Acting Beta Agonists (LABAs) used for the treatment of lung diseases such as asthma and chronic obstructive pulmonary disease (COPD) now carry a black box warning about LABAs increasing the risk of asthma-related death, according to the Food and Drug Administration (FDA). A black box warning is the strongest warning the agency can give and is reserved for drugs that carry a significant risk of serious or even life-threatening adverse events. The new recommendations in the updated labels also state that use of LABAs alone without the use of a long-term asthma control medication, such as ... Read More